Last reviewed · How we verify
Pegylated interferon alfa 2b — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Pegylated interferon alfa 2b (Pegylated interferon alfa 2b) — Kirby Institute.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pegylated interferon alfa 2b TARGET | Pegylated interferon alfa 2b | Kirby Institute | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pegylated interferon alfa 2b CI watch — RSS
- Pegylated interferon alfa 2b CI watch — Atom
- Pegylated interferon alfa 2b CI watch — JSON
- Pegylated interferon alfa 2b alone — RSS
Cite this brief
Drug Landscape (2026). Pegylated interferon alfa 2b — Competitive Intelligence Brief. https://druglandscape.com/ci/pegylated-interferon-alfa-2b. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab